Synthetic Polymer-based Glycol Nanohydrogel Production Service
Advantages of Synthetic Polymers in Developing Nanohydrogels
Synthetic polymers are artificial macromolecules composed of repeating units of monomers, with precise control of their chemical composition, molecular weight, chemical structure, properties, and functions. Synthetic polymers offer significant advantages in custom-developing hydrogels with precise control over their mechanical strength, degradation rate, and porosity. Synthetic polymers often exhibit greater stability and longevity, and this stability is critical to the success of tissue engineering applications that require long-term functionality and durability. With its advanced GlycoNano™ Platform, CD BioGlyco provides clients with worry-free synthetic polymer-based glycol nanohydrogel production services, promoting clients' development and innovative applications in tissue engineering, drug delivery, and other fields.
Fig.1 Applications of polymer-based hydrogels for the various engineering fields. (Thang, et al., 2023)
Customized Nanohydrogels Based on Synthetic Polymers: Tailored Precision for Your Innovative Applications
Hydrogels based on synthetic polymers have tunable properties, reproducibility, and the ability to combine various functions for specific applications. We customize nanohydrogel materials to suit client needs through parameters such as monomer selection, polymerization technology, cross-linking method, and introduction of functional groups. We provide clients with nanohydrogel production services based on synthetic polymers such as polylactic acid (PLA), polyvinyl alcohol (PVA), polylactic-co-glycolic acid (PLGA), poly (l-lactic acid) (PLLA) and polydioxanone (PDO). Our services are as follows:
Preparation Glycol Nanohydrogel
We use free radical polymerization, physical cross-linking, chemical cross-linking, and other methods to connect polymer chains to form a three-dimensional network that retains water molecules. In this process, the reaction conditions, including temperature, pH value, and reactant concentration, are carefully controlled to ensure the formation of hydrogels with the desired size, shape, and swelling properties.
PLGA Glycol Nanohydrogel
We combine the properties of lactic acid and glycolic acid to develop PLGA hydrogels with controlled degradation rates.
PLLA Glycol Nanohydrogel
We aim to provide PLLA hydrogels with strong mechanical strength and stability for medical and pharmaceutical applications.
PDO Glycol Nanohydrogel
We help clients develop fast-degrading PDO glycol nanohydrogels for tissue engineering and medical material applications.
Characterization of Glycol Nanohydrogel
- Swelling: The swelling of hydrogels is crucial to determine parameters such as the degree of crosslinking, mechanical properties, and degradation rate. We determine the gel fraction, swelling ratio measurement, and weight loss of hydrogels.
- Microstructure: The microstructure of hydrogels is formed by physical or chemical crosslinking. We use microscopy techniques such as scanning electron microscopy (SEM) and transmission electron microscopy (TEM) to analyze their porous network. This microstructure affects the permeability, mechanical strength, and biocompatibility of hydrogels.
- Mechanical properties: The mechanical properties of hydrogels are tested by tensile testing, compression testing, indentation testing, bulge testing, cyclic testing, and strip elongation measurement. Good mechanical properties enable hydrogels to maintain their shape and function under load conditions and are suitable for various biomedical and engineering fields.
- Biocompatibility and biodegradability: Biocompatibility protects hydrogels from rejection or negative reactions by organisms, and biodegradability refers to the gradual degradation of hydrogels in the body through biological processes. We use a range of methods to evaluate the biocompatibility and biodegradability of hydrogels, such as cytotoxicity, sensitization-allergic reactions, etc.
Workflow

Applications
- Synthetic polymer-based glycol nanohydrogels are used in the biomedical field, especially in drug delivery systems, due to their excellent biocompatibility and controlled release capabilities.
- In tissue engineering, synthetic polymer-based glycol nanohydrogels are used as scaffold materials to help regenerate tissues and promote cell growth and healing.
- In the field of environmental protection, synthetic polymer-based glycol nanohydrogels are used for wastewater treatment and adsorption of heavy metal ions due to their high water absorption and adjustable chemical properties.
- Synthetic polymer-based glycol nanohydrogels are used as efficient water retainers in agriculture to improve soil structure and retain water, thereby increasing crop yields and drought resistance.
Advantages
- We use advanced synthesis technology to precisely control the chemical and physical properties of hydrogels to ensure the high quality and stability of the product.
- We have mature production processes and equipment to achieve mass production and flexibly adjust the production scale to meet the needs of different clients.
- We have extensive experience in polymer modification and functionalization and customize the properties of hydrogels according to specific application requirements, such as biocompatibility, degradation rate, etc.
- Our technical team has rich experience and expertise, providing a full range of services from product development to technical support to help clients succeed.
Publication Data
DOI: 10.3390/gels10060364
Journal: Gels
Published: 2024
IF: 5.0
Results: The authors added PLA mesh fabric as a reinforcement material to PVA hydrogel to improve the mechanical strength of tissue regeneration scaffolds. The results showed that the addition of PLA mesh fabric did not significantly change the inherent gel content of PVA/PLA composites, but the swelling rate decreased significantly with the increase of PLA mesh layers and heat treatment temperature. When five layers of PLA mesh fabric were added and heat treated at 120°C, the gel strength was the highest. Therefore, the possibility of PLA mesh fabric as a reinforcement material for PVA hydrogel to improve the strength of tissue regeneration scaffolds was confirmed.
Fig.2 Schematic synthesis of PVA/PLA scaffold. (Seo, et al., 2024)
Frequently Asked Questions
- What are the benefits of using glycol nanohydrogels?
Glycol nanohydrogels offer advantages such as biocompatibility, tailored degradation rates, and flexibility in functionalization, making them suitable for biomedical applications, including drug delivery and tissue engineering. -
How are glycol nanohydrogels produced?
Production involves polymerization techniques where monomers are chemically reacted to form a polymer network, incorporating glycol for enhanced properties. Specific conditions and catalysts are employed based on the desired characteristics.
CD BioGlyco uses free radical polymerization, physical crosslinking, chemical crosslinking, and other methods to construct a three-dimensional polymer network that retains water molecules and provides a full range of hydrogel characterization services. If you have any service needs, please feel free to contact us.
References
- Seo, Y.H.; et al. PVA Hydrogels supplemented with PLA mesh for tissue regeneration scaffold. Gels. 2024, 10(6): 364.
- Thang, N.H.; et al. Polymer-based hydrogels applied in drug delivery: An overview. Gels. 2023, 9(7): 523.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





